Skip to main content
Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA.
- Author(s): Gillespie, Brenda W;
- Morgenstern, Hal;
- Hedgeman, Elizabeth;
- Tilea, Anca;
- Scholz, Natalie;
- Shearon, Tempie;
- Burrows, Nilka Rios;
- Shahinian, Vahakn B;
- Yee, Jerry;
- Plantinga, Laura;
- Powe, Neil R;
- McClellan, William;
- Robinson, Bruce;
- Williams, Desmond E;
- Saran, Rajiv
- et al.
Published Web Locationhttps://doi.org/10.1093/ckj/sfv103
BackgroundLonger nephrology care before end-stage renal disease (ESRD) has been linked with better outcomes.
MethodsWe investigated whether longer pre-end-stage renal disease (ESRD) nephrology care was associated with lower mortality at both the patient and state levels among 443 761 incident ESRD patients identified in the USA between 2006 and 2010.
ResultsOverall, 33% of new ESRD patients had received no prior nephrology care, while 28% had received care for >12 months. At the patient level, predictors of >12 months of nephrology care included having health insurance, white race, younger age, diabetes, hypertension and US region. Longer pre-ESRD nephrology care was associated with lower first-year mortality (adjusted hazard ratio = 0.58 for >12 months versus no care; 95% confidence interval 0.57-0.59), higher albumin and hemoglobin, choice of peritoneal dialysis and native fistula and discussion of transplantation options. Living in a state with a 10% higher proportion of patients receiving >12 months of pre-ESRD care was associated with a 9.3% lower relative mortality rate, standardized for case mix (R (2) = 0.47; P < 0.001).
ConclusionsThis study represents the largest cohort of incident ESRD patients to date. Although we did not follow patients before ESRD onset, our findings, both at the individual patient and state levels, reflect the importance of early nephrology care among those with chronic kidney disease.
For improved accessibility of PDF content, download the file to your device.